検索結果 - Ignazio Piseddu
- 検索結果 1 - 9 結果 / 9
-
1
Stringent monitoring can decrease mortality of immune checkpoint inhibitor induced cardiotoxicity 著者: Ying Wang, Carolin Ertl, Carolin Ertl, Christina Schmitt, Linda Hammann, Rafaela Kramer, Ulrich Grabmaier, Florian Schöberl, Florian Schöberl, David Anz, David Anz, Ignazio Piseddu, Ignazio Piseddu, Giulia Pesch, Julio Vera, Waltraud Froehlich, Ludwig Weckbach, Dirk Tomsitz, Carmen Loquai, Lisa Zimmer, Johanna Mangana, Reinhard Dummer, Ralf Gutzmer, Kai-Christian Klespe, Henner Stege, Frank Meiss, Kai-Martin Thoms, Patrick Terheyden, Paul J. Bröckelmann, Douglas B. Johnson, Lars E. French, Lars E. French, Lucie Heinzerling, Lucie Heinzerling, Lucie Heinzerling
出版年 Frontiers in Cardiovascular Medicine (2024-06-01)全文の入手
論文 -
2
Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma 著者: Tilman L. B. Hölting, Florencia Cidre-Aranaz, Dana Matzek, Bastian Popper, Severin J. Jacobi, Cornelius M. Funk, Florian H. Geyer, Jing Li, Ignazio Piseddu, Bruno L. Cadilha, Stephan Ledderose, Jennifer Zwilling, Shunya Ohmura, David Anz, Annette Künkele, Frederick Klauschen, Thomas G. P. Grünewald, Maximilian M. L. Knott
出版年 Molecular Cancer (2022-10-01)全文の入手
論文 -
3
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia 著者: Florian Märkl, Christoph Schultheiß, Murtaza Ali, Shih-Shih Chen, Marina Zintchenko, Lukas Egli, Juliane Mietz, Obinna Chijioke, Lisa Paschold, Sebastijan Spajic, Anne Holtermann, Janina Dörr, Sophia Stock, Andreas Zingg, Heinz Läubli, Ignazio Piseddu, David Anz, Marcus Dühren-von Minden, Tianjiao Zhang, Thomas Nerreter, Michael Hudecek, Susana Minguet, Nicholas Chiorazzi, Sebastian Kobold, Mascha Binder
出版年 Nature Communications (2024-02-01)全文の入手
論文 -
4
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events 著者: Najib Ben Khaled, Marie Möller, Leonie S. Jochheim, Catherine Leyh, Ursula Ehmer, Katrin Böttcher, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Alexander Weich, Hans Benno Leicht, Valentina Zarka, Liangtao Ye, Julia Schneider, Ignazio Piseddu, Osman Öcal, Monika Rau, Friedrich Sinner, Marino Venerito, Simon Johannes Gairing, Friedrich Förster, Julia Mayerle, Enrico N. De Toni, Andreas Geier, Florian P. Reiter
出版年 JHEP Reports (2024-06-01)全文の入手
論文 -
5
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease 著者: Lorenz Kocheise, Lorenz Kocheise, Ignazio Piseddu, Ignazio Piseddu, Joscha Vonderlin, Joscha Vonderlin, Eric T. Tjwa, Eric T. Tjwa, Gustav Buescher, Gustav Buescher, Lucy Meunier, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Francesca Fianchi, Jérôme Dumortier, Jérôme Dumortier, Mar Riveiro Barciela, Mar Riveiro Barciela, Tom J. G. Gevers, Tom J. G. Gevers, Tom J. G. Gevers, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Maria-Carlota Londoño, Sona Frankova, Sona Frankova, Thomas Roesner, Vincent Joerg, Vincent Joerg, Constantin Schmidt, Constantin Schmidt, Fabian Glaser, Fabian Glaser, Jan P. Sutter, Jan P. Sutter, Thorben W. Fründt, Thorben W. Fründt, Ansgar W. Lohse, Ansgar W. Lohse, Samuel Huber, Samuel Huber, Johann von Felden, Johann von Felden, Marcial Sebode, Marcial Sebode, Kornelius Schulze, Kornelius Schulze
出版年 Frontiers in Immunology (2024-01-01)全文の入手
論文 -
6
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease 著者: Lorenz Kocheise, Lorenz Kocheise, Ignazio Piseddu, Ignazio Piseddu, Joscha Vonderlin, Joscha Vonderlin, Eric T. Tjwa, Eric T. Tjwa, Gustav Buescher, Gustav Buescher, Lucy Meunier, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Francesca Fianchi, Jérôme Dumortier, Jérôme Dumortier, Mar Riveiro Barciela, Mar Riveiro Barciela, Tom J. G. Gevers, Tom J. G. Gevers, Tom J. G. Gevers, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Maria-Carlota Londoño, Sona Frankova, Sona Frankova, Thomas Roesner, Vincent Joerg, Vincent Joerg, Constantin Schmidt, Constantin Schmidt, Fabian Glaser, Fabian Glaser, Jan P. Sutter, Jan P. Sutter, Thorben W. Fründt, Thorben W. Fründt, Ansgar W. Lohse, Ansgar W. Lohse, Samuel Huber, Samuel Huber, Johann von Felden, Johann von Felden, Marcial Sebode, Marcial Sebode, Kornelius Schulze, Kornelius Schulze
出版年 Frontiers in Immunology (2024-01-01)全文の入手
論文 -
7
Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced HCC 著者: Najib Ben Khaled, Raphael Mohr, Leonie S. Jochheim, Valentina Zarka, Monika Karin, Fabian Artusa, Julia M. Schütte, Vera Himmelsbach, Ursula Ehmer, Katrin Böttcher, Friedrich Foerster, Simon Johannes Gairing, Paula Bark, Alexander Weich, Ignazio Piseddu, Monika Rau, Bernhard Scheiner, Lorenz Balcar, Marino Venerito, Philipp Heumann, Arne Kandulski, Catherine Leyh, Christoph Roderburg, Tom Lüdde, Matthias Pinter, Julia Mayerle, Jens U. Marquardt, Fabian Finkelmeier, Enrico N. De Toni, Andreas Geier, Florian P. Reiter
出版年 JHEP Reports (2026-06-01)全文の入手
論文 -
8
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab 著者: Lorenz Kocheise, Jan Kempski, Yunhe Tang, Lorenz Balcar, Victoria Berger, Miriam Tomczak, Joao Gorgulho, Ramsha Masood, Franziska Giehren, Constantin Schmidt, Jan P. Sutter, Thorben W. Fruendt, Francesca Pagani, Sophie Wulf, Julian Kött, Saskia Domanig, Anastasios Giannou, Tanja Bedke, Jöran Lücke, Tao Zhang, Siwen Zhang, Andres Machicote, Ansgar W. Lohse, Marianna Alunni-Fabbroni, Jens Ricke, Najib Ben Khaled, Matthias Pinter, Bernhard Scheiner, Samuel Huber, Johann von Felden, Ignazio Piseddu, Kornelius Schulze
出版年 Annals of Hepatology (2026-01-01)全文の入手
論文 -
9
Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-H... 著者: Najib Ben Khaled, Ursula Ehmer, Ilja Kubisch, Maria A. Gonzalez-Carmona, Alexander Philipp, Max Seidensticker, Julia Altenhofer, Marion Basch, Tim Hüwer, Bettina Oehrle, Andreas Geier, Caterina Soldà, Alessandra Auriemma, Ulrike Bauer, Taotao Zhou, Lukas Perkhofer, Jack Chater, Arndt Weinmann, Johann von Felden, Antonio De Rosa, Caterina Vivaldi, Ignazio Piseddu, Isabel Schwald, Stefan Enssle, Monika Karin, Julia S. Schneider, Moritz N. Gröper, Katarina Ondrejkova, Lena Weiss, Georg Beyer, Kornelius Schulze, Lorenzo Antonuzzo, Gianluca Masi, Bruno Daniele, Jens Ricke, Julia Mayerle, Friedrich Foerster, Florian P. Reiter, Thomas J. Ettrich, Enrico N. De Toni
出版年 Therapeutic Advances in Medical Oncology (2026-02-01)全文の入手
論文
